Biogen Investors: Active Ingredient In Patient Death Is Not Changing BofA's Forecast

By: via Benzinga
Bank of America commented on Biogen Inc (NASDAQ: BIIB) Wednesday following the death of a patient due to fatal progressive multifocal ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.